Ulceroglandular tularemia in a nonendemic area

Southern Medical Journal

Volumn 100, Issue 3, 2007, Pages 304-308

  Guffey, M Brad ^b   Dalzell, Alex ^b   Kelly, David R ^b   Cassady, Kevin A ^a  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

Francisella tularensis; Pediatrics; Tularemia; Ulceroglandular syndrome; Zoonosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; GENTAMICIN; SULTAMICILLIN;

ANAMNESIS; ARTICLE; BACTERIUM CULTURE; BARTONELLA HENSELAE; BIOPSY; CASE REPORT; CLINICAL FEATURE; FEMALE; FRANCISELLA TULARENSIS; GRAM STAINING; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SURGICAL DRAINAGE; TULAREMIA; ULCER; AXILLA; CHILD; HAND DISEASE; LYMPHADENITIS; MICROBIOLOGY; REVIEW; SKIN ULCER; THORAX;

AXILLA; CHILD; CHILD, PRESCHOOL; FEMALE; HAND DERMATOSES; HUMANS; LYMPHADENITIS; MALE; SKIN ULCER; THORAX; TULAREMIA;

EID: 34247592411     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000242333.60112.7f     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Tularemia: United States, 1990-2000. MMWR Morb Mortal Wkly Rep 2002;51:181-184.
2. Amsden JR, Warmack S, Gubbins PO. Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review. Pharmacotherapy 2005;25:191-210.
3. Baldwin CJ, Panciera RJ, Morton RJ, et al. Acute tularemia in three domestic cats. J Am Vet Med Assoc 1991;199:1602-1605.
4. Centers for Disease Control and Prevention. Tularemia transmitted by insect bites: Wyoming, 2001-2003. MMWR Morb Mortal Wkly Rep 2005;54:170-173.
5. Hornick R. Tularemia revisited. N Engl J Med 2001;345:1637-1639.
6. Dembek ZF, Buckman RL, Fowler SK, et al. Missed sentinel case of naturally occurring pneumonic tularemia outbreak: lessons for detection of bioterrorism. J Am Board Fam Pract 2003;16:339-342.
7. Weinberg AN. Commentary: Wherry WB, Lamb BH: Infection of man with Bacterium tularense. J Infect Dis 1914;15:331-40. J Infect Dis 2004;189:1317-1320.
8. Ohara Y, Sato T, Homma M. Arthropod-borne tularemia in Japan: clinical analysis of 1,374 cases observed between 1924 and 1996. J Med Entomol 1998;35:471-473.
9. Ohara S. Studies on yato-byo (Ohara's disease, tularemia in Japan): I. Jpn J Exp Med 1954;24:69-79.
10. Uhari M, Syrjala H, Salminen A. Tularemia in children caused by Francisella tularensis biovar palaearctica. Pediatr Infect Dis J 1990;9:80-83.
11. Quan SF, McManus AG, Von Fintel H. Infectivity of tularemia applied to intact skin and ingested in drinking water. Science 1956;123:942-943.
12. Evans ME, Gregory DW, Schaffner W, et al. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985;64:251-269.
13. Shapiro DS, Schwartz DR. Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure. J Clin Microbiol 2002;40:2278-2281.
14. Cerny Z. Changes of the epidemiology and the clinical picture of tularemia in Southern Moravia (the Czech Republic) during the period 1936-1999. Eur J Epidemiol 2001;17:637-642.
15. Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 1976;13:105-114.
16. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep 1997;46:1-55.
17. Koskela P, Salminen A. Humoral immunity against Francisella tularensis after natural infection. J Clin Microbiol 1985;22:973-979.
18. Johansson A, Berglund L, Eriksson U, et al. Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 2000;38:22-26.
19. Enderlin G, Morales L, Jacobs RF, et al. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994;19:42-47.
20. Cross JT, Jacobs RF. Tularemia: treatment failures with outpatient use of ceftriaxone. Clin Infect Dis 1993;17:976-980.
21. Cross JT Jr, Schutze GE, Jacobs RF. Treatment of tularemia with gentamicin in pediatric patients. Pediatr Infect Dis J 1995;14:151-152.
22. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763-2773.
23. Russell P, Eley SM, Fulop MJ, et al. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia. J Antimicrob Chemother 1998;41:461-465.
24. Feldman KA, Enscore RE, Lathrop SL, et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med 2001;345:1601-1606.
25. Siret V, Barataud D, Prat M, et al. An outbreak of airborne tularaemia in France, August 2004. Euro Surveill 2006;11:50-60.
26. Jensen WA, Kirsch CM Tularemia. Semin Respir Infect 2003;18:146-158.
27. Christopher GW, Cieslak TJ, Pavlin JA, et al. Biological warfare: a historical perspective. JAMA 1997;278:412-417.
28. Jacobs RF. Tularemia. Adv Pediatr Infect Dis 1996;12:55-69.
29. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278:399-411.
30. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis 1997;3:83-94.
31. Jacobs RF, Condrey YM, Yamauchi T. Tularemia in adults and children: a changing presentation. Pediatrics 1985;76:818-822.